MILWAUKEE, WI – St. Luke’s Medical Center today announced the acquisition of the Intuitive da Vinci 5 (dV5) surgical system, marking a major milestone in the institution’s ongoing commitment to delivering world-class, state-of-the-art care to women facing complex gynecologic cancers.
The introduction of the dV5 platform significantly advances the robotic surgery capabilities at St. Luke’s Medical Center. Designed to foster seamless intraoperative collaboration, the platform supports a unified, multidisciplinary team approach to oncologic surgery. By integrating advanced digital connectivity, enhanced visualization, and tactile feedback, the dV5 enables surgical teams to work with heightened precision and efficiency during high-stakes procedures.
Key technological advancements of the dV5 system include:
“The acquisition of the da Vinci 5 platform represents a transformative step forward for our surgical program,” said Dr. Scott Kamelle, a leading Gynecologic Oncologist practicing at St. Luke’s. “Robotic technology is not just about the equipment—it is about empowering the entire surgical team to collaborate more effectively in real time. The dV5’s enhanced visualization and refined control allow us to perform highly intricate oncologic procedures with greater efficiency, lower impact on surrounding tissues, and ultimately, better outcomes for our patients.”
The integration of the dV5 platform further solidifies St. Luke’s Medical Center as a regional leader in minimally invasive gynecologic oncology. It also bolsters the clinical practice of Dr. Scott Kamelle, who stands as one of the most experienced robotic surgeons in the Midwest, having performed nearly 4,000 robotic surgical procedures over his distinguished career.
Dr. Scott Kamelle brings decades of specialized experience to the program. After completing his internship and residency at the Hospital of the University of Pennsylvania, he pursued fellowship training in Gynecologic Oncology at the University of Oklahoma Health Sciences Center. His career highlights include serving as Director of Gynecological Oncology at Aurora Health Care, chairing Aurora’s Robotic Steering Committee for over a decade, and serving as an Associate Professor at the University of Wisconsin-Madison School of Medicine.
Beyond his clinical leadership, Dr. Scott Kamelle remains actively engaged in clinical research aimed at expanding treatment options for gynecologic malignancies, supported by grants such as the Aurora Cancer Care Research Institute grant. His patient-centered philosophy emphasizes personalized treatment plans, shared decision-making, and continuous patient education.
The addition of the da Vinci 5 platform underscores St. Luke’s Medical Center and Dr. Scott Kamelle’s shared dedication to pushing the boundaries of surgical innovation, shortening recovery times, and improving the quality of life for women battling gynecologic cancers.
About Dr. Scott Kamelle
Dr. Scott Kamelle is a highly respected Gynecologic Oncologist practicing in the Midwest. Dedicated to providing compassionate, individualized care, Dr. Scott Kamelle specializes in advanced minimally invasive and robotic surgical techniques for gynecologic cancers. Through clinical excellence, academic mentorship, and patient advocacy, he remains committed to improving healthcare outcomes for women. To learn more or read updates on the latest advancements in gynecologic oncology, visit drscottkamelle.org or his official website below.
Media ContactCompany Name: Dr. Scott KamelleContact Person: Dr. Scott KamelleEmail: Send EmailCity: MilwaukeeState: WisconsinCountry: United StatesWebsite: https://drscottkamelle.com/
